Literature DB >> 11123431

Enhanced cell killing by overexpression of dominant-negative phosphatidylinositol 3-kinase subunit, Deltap85, following genotoxic stresses.

S Tachiiri1, K Sasai, N Oya, M Hiraoka.   

Abstract

Phosphatidylinositol 3-kinase (PI3-K) is a heterodimer of a regulatory subunit, p85, and a catalytic subunit, p110. A number of previous reports showed that PI3-K functions in diverse cellular phenomena such as cell proliferation, glucose catabolism, cell adhesion, and vesicle transport. It is also well known that a survival signal from the receptor tyrosine kinases utilizes Akt via PI3-K to protect cells from apoptosis. To examine the role of PI3-K in cellular sensitivity to genotoxic stresses such as cisplatin and ultraviolet (UV), we introduced deletion type p85 (Dp85) into two human glioblastoma cell lines (T98G and A172) and one melanoma cell line (G361). The Deltap85 works in a dominant-negative fashion on PI3-K activity by disrupting its p85 / p110 interaction. In all three transfected cell lines, the overexpression of Deltap85 rendered the cells markedly more sensitive to these DNA-damaging stresses than the cells transfected with the vector alone. Apoptosis was vigorously induced in cells overexpressing Dp85 following the treatment. The present results imply that PI3-K plays a critical role in determining cellular sensitivity to genotoxic stresses in human cancer cells, and that disruption of the p85 / p110 interaction of PI3-K may be a potential molecular target for developing a novel strategy for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123431      PMCID: PMC5926311          DOI: 10.1111/j.1349-7006.2000.tb00919.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.

Authors:  N Takuwa; Y Fukui; Y Takuwa
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 2.  Phosphoinositide kinases.

Authors:  C L Carpenter; L C Cantley
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

Review 3.  PI3K: downstream AKTion blocks apoptosis.

Authors:  T F Franke; D R Kaplan; L C Cantley
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

4.  Influence of the proto-oncogene c-fos on cisplatin sensitivity.

Authors:  R A Moorehead; G Singh
Journal:  Biochem Pharmacol       Date:  2000-02-15       Impact factor: 5.858

5.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.

Authors:  A Khwaja; P Rodriguez-Viciana; S Wennström; P H Warne; J Downward
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  Acquisition of resistance to apoptosis and necrosis by Bcl-xL over-expression in rat hepatoma McA-RH8994 cells.

Authors:  K Fukuda; M Yamamoto
Journal:  J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 4.029

7.  The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

Authors:  S G Kennedy; A J Wagner; S D Conzen; J Jordán; A Bellacosa; P N Tsichlis; N Hay
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

8.  Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein.

Authors:  S Pugazhenthi; A Nesterova; C Sable; K A Heidenreich; L M Boxer; L E Heasley; J E Reusch
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

9.  Expression of activated c-erbB-2 oncogene induces sensitivity to cisplatin in human gallbladder adenocarcinoma cells.

Authors:  V Boudny; Y Murakami; S Nakano; Y Niho
Journal:  Anticancer Res       Date:  1999 Nov-Dec       Impact factor: 2.480

10.  PIK3CA is implicated as an oncogene in ovarian cancer.

Authors:  L Shayesteh; Y Lu; W L Kuo; R Baldocchi; T Godfrey; C Collins; D Pinkel; B Powell; G B Mills; J W Gray
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more
  4 in total

1.  Similar effects of Brca2 truncation and Rad51 paralog deficiency on immunoglobulin V gene diversification in DT40 cells support an early role for Rad51 paralogs in homologous recombination.

Authors:  Atsushi Hatanaka; Mitsuyoshi Yamazoe; Julian E Sale; Minoru Takata; Kazuhiko Yamamoto; Hiroyuki Kitao; Eiichiro Sonoda; Koji Kikuchi; Yasukazu Yonetani; Shunichi Takeda
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 2.  The Akt signaling pathway: an emerging therapeutic target in malignant melanoma.

Authors:  SubbaRao V Madhunapantula; Paul J Mosca; Gavin P Robertson
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

Review 3.  The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-28       Impact factor: 4.693

4.  Therapeutic Implications of Targeting AKT Signaling in Melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Enzyme Res       Date:  2011-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.